Search alternatives:
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
clinical decrease » clinical disease (Expand Search), clinical case (Expand Search), clinical areas (Expand Search)
linear decrease » linear increase (Expand Search)
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
clinical decrease » clinical disease (Expand Search), clinical case (Expand Search), clinical areas (Expand Search)
linear decrease » linear increase (Expand Search)
-
2061
-
2062
-
2063
-
2064
-
2065
-
2066
-
2067
-
2068
-
2069
Characterization of systolic pulmonary arterial pressure (sPAP) of WT BMP9 in rats.
Published 2025Subjects: -
2070
Pharmacological characterization of WT BMP9 and A347E variant <i>in vitro</i> and <i>in vivo.</i>
Published 2025Subjects: -
2071
-
2072
Evaluation of chronic <i>in vivo</i> efficacy in 21 days rat MCT model in prevention mode.
Published 2025Subjects: -
2073
-
2074
Evaluation of chronic <i>in vivo</i> efficacy in 21 days rat MCT model in prevention mode.
Published 2025Subjects: -
2075
-
2076
Pharmacological characterization of WT BMP9 and A347E variant <i>in vitro</i> and <i>in vivo.</i>
Published 2025Subjects: -
2077
-
2078
Clinical symptoms scoring system.
Published 2025“…Vaccination against canine leishmaniasis intends to decrease the parasite burden and the risk of clinical disease. …”
-
2079
-
2080